查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1756406

CRISPR 和 Cas 基因市場，按產品類型、按技術、按交付方式、按治療領域、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

CRISPR And Cas Genes Market, By Product Type, By Technology, By Delivery Method, By Therapeutic Area, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年 CRISPR 和 Cas 基因市場規模價值 47.0129 億美元，2025 年至 2032 年的複合年成長率為 16.50%。

CRISPR 和 Cas 基因市場-市場動態

精準基因編輯技術的進步加速市場成長

精準基因編輯技術的進步，尤其是 CRISPR 和 Cas 基因的進步，正在顯著加速全球研究和治療應用。根據美國國立衛生研究院 (NIH) 的數據，目前超過 70% 的基因編輯臨床試驗都集中在 CRISPR-Cas 系統上，因為它們精準且有效率。美國食品藥物管理局 (FDA) 最近批准了幾種利用這些工具的基因療法，反映出監管機構的認可度不斷提高。此外，人類基因組計畫等全球性計畫不斷拓展人們對遺傳疾病的理解，推動了對精準基因編輯解決方案的需求。然而，脫靶效應和倫理考量等挑戰依然存在，這為改善安全性和給藥方案的創新創造了機會。這些進步正在建立一個充滿活力的格局，精準基因編輯在解決複雜遺傳疾病和推進個人化醫療方面發揮關鍵作用。

CRISPR 和 Cas 基因市場—關鍵洞察

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 16.50%。

根據產品類型細分，預計該產品將在 2024 年佔據最大市場佔有率

根據技術細分，CRISPR/Cas9 是 2024 年的領先技術

根據遞送方式細分，病毒載體是 2024 年最主要的遞送方式

根據治療領域細分，腫瘤學是 2024 年領先的治療領域

根據最終用戶細分，生物技術和製藥公司是 2024 年領先的最終用戶

按地區分類，北美是 2024 年的主要收入來源

CRISPR 和 Cas 基因市場-細分分析：

全球 CRISPR 和 Cas 基因市場根據產品類型、技術、交付方式、治療領域、最終用戶和地區進行細分。

根據產品類型，市場分為兩類：產品（試劑盒、試劑和文庫）和服務（微生物基因編輯、細胞株工程、gRNA 設計與合成、DNA 合成、篩選服務及其他）。產品類別以試劑盒和試劑（包括 Cas 蛋白和嚮導 RNA）為主，其次是以設計工具和抗體為特色的文庫。服務專注於微生物基因編輯、細胞株工程、gRNA 設計、DNA 合成和篩選，支援全球全面的基因編輯工作流程。

根據技術，市場分為三類：CRISPR/Cas9、CRISPR/Cas12、CRISPR/Cas13 和其他。 CRISPR/Cas9 在精準基因編輯應用領域佔據主導地位，其次是用於診斷和治療的 CRISPR/Cas12。 CRISPR/Cas13 專注於 RNA 靶向，而其他技術則包括新興變體，正在拓展其在全球研究和臨床領域的能力。

CRISPR 和 Cas 基因市場—地理洞察

在強大的科學研究基礎設施和政府支持的推動下，CRISPR 和 Cas 基因市場在北美、歐洲和亞太地區表現強勁。北美市場領先，得益於美國國立衛生研究院等機構的大量資金投入，以及波士頓和舊金山等領先生物技術中心的設立。歐洲緊隨其後，德國、英國和法國等國家透過歐盟「地平線」計畫支持的措施推進基因編輯研究。亞太地區發展迅速，尤其是在中國、日本和韓國，這些國家不斷增加的生物技術投資和配套的監管框架正在促進創新和商業化。拉丁美洲和中東的新興市場也開始將基因編輯技術應用於醫療保健和農業，儘管速度較慢。全球性的合作和學術夥伴關係正在進一步加強 CRISPR 和 Cas 基因的全球影響力，凸顯了區域專業知識和資源可用性在推動市場發展中的重要性。

CRISPR 和 Cas 基因市場—競爭格局：

CRISPR 和 Cas 基因市場的競爭格局由主要生物技術公司、學術機構和專注於推進基因編輯技術的創新新創公司塑造。 Editas Medicine、CRISPR Therapeutics 和 Intellia Therapeutics 等主要參與者正在積極開發專有的 CRISPR-Cas 平台，並透過策略合作和授權協議拓展其技術能力。學術研究中心透過發現新的 Cas 變體和改進遞送方法做出了重要貢獻，從而推動了創新。新創公司也湧現出包括鹼基編輯和主要編輯在內的利基技術，以提高精確度並減少脫靶效應。智慧財產權發揮著至關重要的作用，持續的專利糾紛影響著競爭態勢。與製藥公司和研究機構的合作加速了治療藥物的開發和商業化。此外，隨著企業努力滿足全球治療和農業應用領域日益成長的需求，對可擴展生產和改進的生物資訊工具的研發投入正在加劇競爭。

最新動態：

2024年11月，Vertex與CRISPR Therapeutics獲得全球首個基於CRISPR/Cas9的基因編輯療法CASGEVY的授權，用於治療鐮狀細胞病和輸血依賴性BETA地中海貧血，標誌著CRISPR和Cas基因技術臨床應用的重要里程碑。

2024年8月，CRISPR QC在其CRISPR分析平台中推出了三款創新產品－RNP形成、DNA標靶結合和CLEAVE，為CRISPR/Cas基因編輯工作流程提供即時洞察。這些工具最佳化了基因編輯研究和治療開發的效率、準確性和品質控制。

2025年1月，奧胡斯大學的研究人員發表了一項三重作用的CRISPR技術，能夠同時在人類原代T細胞中實現基因活化、抑制和刪除。這項突破性進展利用了多個CRISPR/Cas系統，推動了複雜的基因工程在細胞治療和再生醫學領域的應用。

目錄

第1章：CRISPR 和 Cas 基因市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • CRISPR 和 Cas 基因市場片段（依產品類型）
    • CRISPR 和 Cas 基因市場技術片段
    • CRISPR 和 Cas 基因市場片段（以交付方式）
    • CRISPR 和 Cas 基因市場片段（按治療領域）
    • CRISPR 和 Cas 基因市場片段（按最終用戶）
    • CRISPR 和 Cas 基因市場（按國家/地區）
    • CRISPR 和 Cas 基因市場（按地區）
  • 競爭洞察

第3章：CRISPR 和 Cas 基因關鍵市場趨勢

  • CRISPR 和 Cas 基因市場促進因素
    • 市場促進因素的影響分析
  • CRISPR 和 Cas 基因市場限制
    • 市場限制的影響分析
  • CRISPR 和 Cas 基因的市場機會
  • CRISPR 和 Cas 基因市場未來趨勢

第4章：CRISPR 和 Cas 基因產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：CRISPR 與 Cas 基因市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：CRISPR 和 Cas 基因市場模式

  • 2024年CRISPR和Cas基因市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：CRISPR 和 Cas 基因市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 產品
      • 試劑盒和試劑
      • Cas 蛋白和酶
      • 嚮導RNA
      • 其他
      • 圖書館
      • 設計工具
      • 抗體
      • 其他
    • 服務
      • 微生物基因編輯
      • 細胞株工程
      • gRNA設計與合成
      • DNA合成
      • 篩檢服務
      • 其他

第 8 章：CRISPR 和 Cas 基因市場 - 按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • CRISPR/Cas9
    • CRISPR/Cas12
    • CRISPR/Cas13
    • 其他

第9章：CRISPR 和 Cas 基因市場 - 按交付方式

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 物理方法（電穿孔、顯微注射）
    • 病毒載體
    • 非病毒載體

第10章：CRISPR 和 Cas 基因市場 - 按治療領域

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 腫瘤學
    • 遺傳性疾病
    • 傳染病
    • 其他

第 11 章：CRISPR 和 Cas 基因市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 生技與製藥公司
    • 學術和政府研究機構
    • 合約研究組織（CRO）

第 12 章：CRISPR 和 Cas 基因市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美 CRISPR 和 Cas 基因主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模及預測（以交付方式）
    • 北美市場規模及預測（按治療領域）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲CRISPR和Cas基因主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（以交付方式）
    • 歐洲市場規模及預測（按治療領域）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區 CRISPR 和 Cas 基因主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（以交付方式）
    • 亞太地區市場規模及預測（依治療領域）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲的 CRISPR 和 Cas 基因主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（以交付方式）
    • 拉丁美洲市場規模及預測（按治療領域）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲的 CRISPR 和 Cas 基因主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（以交付方式）
    • 中東和非洲市場規模及預測（按治療領域）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：關鍵供應商分析 - CRISPR 和 Cas 基因產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Addgene
    • Beam Therapeutics
    • Caribou Biosciences
    • CRISPR Therapeutics AG
    • Editas Medicine
    • GenScript Biotech Corporation
    • Horizon Discovery Group
    • Integrated DNA Technologies (IDT)
    • Intellia Therapeutics
    • Mammoth Biosciences
    • Merck KGaA (Sigma-Aldrich)
    • New England Biolabs
    • Precision BioSciences
    • Synthego Corporation
    • Thermo Fisher Scientific
    • ToolGen Inc.
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5305

REPORT HIGHLIGHT

CRISPR And Cas Genes Market size was valued at US$ 4,701.29 Million in 2024, expanding at a CAGR of 16.50% from 2025 to 2032.

The CRISPR and Cas Genes Market involves advanced gene-editing technologies used for precise genetic modifications across research, therapeutic, and agricultural applications. Increasing adoption of gene-editing tools for developing personalized medicine and disease-resistant crops boosts innovation, while challenges like ethical concerns and regulatory hurdles limit rapid growth. Growing investments in genetic research have led to a surge in CRISPR patent filings, with over 3,000 patents recorded by major institutions globally. Opportunities lie in expanding applications in rare genetic disorders and regenerative medicine, supported by initiatives from organizations like the National Institutes of Health (NIH), promoting genome editing research. However, complexities in delivery methods and off-target effects pose restraints, underscoring the need for improved accuracy and safety in gene-editing practices.

CRISPR And Cas Genes Market- Market Dynamics

Advancements in Precision Gene Editing to Accelerate Market Growth

Advancements in precision gene editing technologies, particularly involving CRISPR and Cas genes, are significantly accelerating research and therapeutic applications worldwide. According to the National Institutes of Health (NIH), over 70% of gene-editing clinical trials currently focus on CRISPR-Cas systems due to their accuracy and efficiency. The U.S. Food and Drug Administration (FDA) has recently approved several gene therapies utilizing these tools, reflecting growing regulatory acceptance. Furthermore, global initiatives like the Human Genome Project continue to expand understanding of genetic diseases, fueling demand for precise gene-editing solutions. However, challenges such as off-target effects and ethical considerations persist, opening opportunities for innovations that improve safety and delivery. These advancements are fostering a dynamic landscape where precision gene editing plays a pivotal role in addressing complex genetic disorders and advancing personalized medicine.

CRISPR And Cas Genes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.50% over the forecast period (2025-2032)

Based on product type segmentation, the Product was predicted to show maximum market share in the year 2024

Based on Technology segmentation, CRISPR/Cas9 was the leading Technology in 2024

Based on Delivery Method segmentation, Viral Vectors were the leading Delivery Method in 2024

Based on Therapeutic Area segmentation, Oncology was the leading Therapeutic Area in 2024

Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

CRISPR And Cas Genes Market- Segmentation Analysis:

The Global CRISPR and Cas Genes Market is segmented on the basis of Product Type, Technology, Delivery Method, Therapeutic Area, End User, and Region.

The market is divided into two categories based on product type: Product (Kits & Reagents and Libraries), and Service (Microbial Gene Editing, Cell Line Engineering, gRNA Design & Synthesis, DNA Synthesis, Screening Services, and Others). Product segment leads with Kits & Reagents, including Cas Proteins and Guide RNA, followed by Libraries featuring design tools and antibodies. Services focus on microbial gene editing, cell line engineering, gRNA design, DNA synthesis, and screening, supporting comprehensive gene-editing workflows globally.

The market is divided into three categories based on Technology: CRISPR/Cas9, CRISPR/Cas12, CRISPR/Cas13, and Others. CRISPR/Cas9 dominates with precise gene editing applications, followed by CRISPR/Cas12 used in diagnostics and therapeutics. CRISPR/Cas13 specializes in RNA targeting, while others include emerging variants expanding capabilities across research and clinical settings worldwide.

CRISPR And Cas Genes Market- Geographical Insights

The CRISPR and Cas Genes market shows strong activity across North America, Europe, and Asia-Pacific, driven by robust research infrastructure and government support. North America leads due to substantial funding from agencies like the National Institutes of Health and the presence of leading biotech hubs such as Boston and San Francisco. Europe follows closely, with countries like Germany, the UK, and France advancing gene-editing research through initiatives supported by the European Union's Horizon programs. Asia-Pacific is rapidly growing, especially in China, Japan, and South Korea, where increasing investments in biotechnology and supportive regulatory frameworks are fostering innovation and commercialization. Emerging markets in Latin America and the Middle East are beginning to adopt gene-editing technologies for healthcare and agricultural applications, although at a slower pace. Collaborative efforts and academic partnerships worldwide are further strengthening the global footprint of CRISPR and Cas genes, highlighting the importance of regional expertise and resource availability in advancing the market.

CRISPR And Cas Genes Market- Competitive Landscape:

The competitive landscape of the CRISPR and Cas Genes market is shaped by key biotechnology companies, academic institutions, and innovative startups focusing on advancing gene-editing technologies. Major players such as Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics are actively developing proprietary CRISPR-Cas platforms, with strategic collaborations and licensing agreements expanding their technological capabilities. Academic research centers contribute significantly by discovering new Cas variants and improving delivery methods, fueling innovation. Startups are also emerging with niche technologies, including base editing and prime editing, enhancing precision and reducing off-target effects. Intellectual property rights play a critical role, with ongoing patent disputes influencing competitive dynamics. Partnerships with pharmaceutical companies and research organizations accelerate therapeutic development and commercialization efforts. Additionally, investment in R&D for scalable production and improved bioinformatics tools is intensifying competition, as firms strive to meet growing demand across therapeutic and agricultural applications globally.

Recent Developments:

In November 2024, Vertex and CRISPR Therapeutics received authorization for the world's first CRISPR/Cas9-based gene editing therapy, CASGEVY, for sickle cell disease and transfusion-dependent beta thalassemia, marking a major milestone in the clinical application of CRISPR and Cas gene technologies.

In August 2024, CRISPR QC launched three innovative products-RNP Formation, DNA Target Binding, and CLEAVE-within its CRISPR Analytics Platform, offering real-time insights into CRISPR/Cas gene editing workflows. These tools optimize efficiency, accuracy, and quality control for gene editing research and therapeutic development.

In January 2025, Researchers at Aarhus University unveiled a triple-action CRISPR technology enabling simultaneous gene activation, repression, and deletion in primary human T cells. This breakthrough uses multiple CRISPR/Cas systems, advancing complex genetic engineering for cell therapy and regenerative medicine applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Addgene
  • Beam Therapeutics
  • Caribou Biosciences
  • CRISPR Therapeutics AG
  • Editas Medicine
  • GenScript Biotech Corporation
  • Horizon Discovery Group
  • Integrated DNA Technologies (IDT)
  • Intellia Therapeutics
  • Mammoth Biosciences
  • Merck KGaA (Sigma-Aldrich)
  • New England Biolabs
  • Precision BioSciences
  • Synthego Corporation
  • Thermo Fisher Scientific
  • ToolGen Inc.
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Product
  • Kits & Reagents
  • Cas Proteins & Enzymes
  • Guide RNA
  • Others
  • Libraries
  • Design Tool
  • Antibodies
  • Others
  • Service
  • Microbial Gene Editing
  • Cell Line Engineering
  • gRNA Design & Synthesis
  • DNA Synthesis
  • Screening Services
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • CRISPR/Cas9
  • CRISPR/Cas12
  • CRISPR/Cas13
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Physical Methods (Electroporation, Microinjection)
  • Viral Vectors
  • Non-Viral Vectors

GLOBAL CRISPR AND CAS GENES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL CRISPR AND CAS GENES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR And Cas Genes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR And Cas Genes Market Snippet by Product Type
    • 2.1.2. CRISPR And Cas Genes Market Snippet by Technology
    • 2.1.3. CRISPR And Cas Genes Market Snippet by Delivery Method
    • 2.1.4. CRISPR And Cas Genes Market Snippet by Therapeutic Area
    • 2.1.5. CRISPR And Cas Genes Market Snippet by End User
    • 2.1.6. CRISPR And Cas Genes Market Snippet by Country
    • 2.1.7. CRISPR And Cas Genes Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR And Cas Genes Key Market Trends

  • 3.1. CRISPR And Cas Genes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR And Cas Genes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR And Cas Genes Market Opportunities
  • 3.4. CRISPR And Cas Genes Market Future Trends

4. CRISPR And Cas Genes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR And Cas Genes Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR And Cas Genes Market Landscape

  • 6.1. CRISPR And Cas Genes Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR And Cas Genes Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Product
      • 7.1.2.1. Kits & Reagents
      • 7.1.2.1.1. Cas Proteins & Enzymes
      • 7.1.2.1.2. Guide RNA
      • 7.1.2.1.3. Others
      • 7.1.2.2. Libraries
      • 7.1.2.2.1. Design Tool
      • 7.1.2.2.2. Antibodies
      • 7.1.2.2.3. Others
    • 7.1.3. Service
      • 7.1.3.1. Microbial Gene Editing
      • 7.1.3.2. Cell Line Engineering
      • 7.1.3.3. gRNA Design & Synthesis
      • 7.1.3.4. DNA Synthesis
      • 7.1.3.5. Screening Services
      • 7.1.3.6. Others

8. CRISPR And Cas Genes Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. CRISPR/Cas9
    • 8.1.3. CRISPR/Cas12
    • 8.1.4. CRISPR/Cas13
    • 8.1.5. Others

9. CRISPR And Cas Genes Market - By Delivery Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 9.1.2. Physical Methods (Electroporation, Microinjection)
    • 9.1.3. Viral Vectors
    • 9.1.4. Non-Viral Vectors

10. CRISPR And Cas Genes Market - By Therapeutic Area

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 10.1.2. Oncology
    • 10.1.3. Genetic Disorders
    • 10.1.4. Infectious Diseases
    • 10.1.5. Others

11. CRISPR And Cas Genes Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Biotechnology & Pharmaceutical Companies
    • 11.1.3. Academic & Government Research Institutes
    • 11.1.4. Contract Research Organizations (CROs)

12. CRISPR And Cas Genes Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. CRISPR And Cas Genes Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. CRISPR And Cas Genes Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. CRISPR And Cas Genes Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. CRISPR And Cas Genes Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. CRISPR And Cas Genes Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- CRISPR And Cas Genes Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Addgene
    • 13.2.2. Beam Therapeutics
    • 13.2.3. Caribou Biosciences
    • 13.2.4. CRISPR Therapeutics AG
    • 13.2.5. Editas Medicine
    • 13.2.6. GenScript Biotech Corporation
    • 13.2.7. Horizon Discovery Group
    • 13.2.8. Integrated DNA Technologies (IDT)
    • 13.2.9. Intellia Therapeutics
    • 13.2.10. Mammoth Biosciences
    • 13.2.11. Merck KGaA (Sigma-Aldrich)
    • 13.2.12. New England Biolabs
    • 13.2.13. Precision BioSciences
    • 13.2.14. Synthego Corporation
    • 13.2.15. Thermo Fisher Scientific
    • 13.2.16. ToolGen Inc.
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us